Loading clinical trials...
Loading clinical trials...
Brief Summary The purpose of this study is to better characterize the retina and optic nerve in newborns using spectral domain optical coherence tomography (s-oct). This new technology provides a ver...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
NCT07165626 · Epiretinal Membrane, Macular Oedema, and more
NCT07338461 · Normal Eyes, Age Related Macular Degeneration, and more
NCT06841575 · Eye Diseases, Retinal Disease, and more
NCT06011798 · Diabetic Macular Edema, Retinal Disease, and more
NCT02946879 · Leber Congenital Amaurosis (LCA), Eye Diseases, and more
Los Angeles Biomedical Research Institute atHarbor-UCLA Medical Center
Torrance, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions